Komori
OLBA DVx HEALTHCARE (2689) · InitiativeContinued decline in equipment and supplies sales and development of a new business base

Expanding orders for large-scale equipment and modalities

First written in FY2016. 15 of 36 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.

36entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q1 – FY2019AdvancedFY2021-Q3 – FY2022OtherFY2025-H1 – FY20262016: 22017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 120252026: 22026
Same theme, other companies
Expanding orders for large-scale equipment and diagnostic imaging equipmentA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Continued decline in equipment and supplies sales and development of a new business baseAnnual report

    「Equipment and supplies revenue struggled, falling 3.0% from the previous fiscal year amid a challenging operating environment for medical institutions. However, contracts for Temasac®, a self-service payment terminal for clinics and a new business initiative, are growing steadily. The low-temperature pyrolysis upcycling unit OLSTECH®, a next-generation waste treatment machine developed by オルシード, which was established on 6 January 2025, is also steadily establishing the foundation for future market expansion.」

    While equipment and supplies revenue fell 3.0% from the previous fiscal year, the company is expanding contracts for self-service payment terminals for clinics and continuing to establish the foundation for the market rollout of OLSTECH.
  2. FY2026-H1Continued equipment and supplies revenue decline and progress in new businessesAnnual report

    「Equipment and supplies revenue fell 1.6% year on year, reflecting the fact that equipment and supplies revenue in the second quarter of the previous fiscal year was higher than usual. Meanwhile, contracts for the self-service payment terminal for clinics, Temasac®, a new business initiative, are growing steadily. OLS TECH®, a next-generation waste treatment machine, the low-temperature pyrolysis upcycling unit, developed by オルシード, which was established on 6 January 2025, is also steadily establishing the foundation for future market expansion.」

    While equipment and supplies revenue fell 1.6% year on year, the company is increasing contracts for self-service payment terminals for clinics and establishing the foundation for the market rollout of OLSTECH.
  3. FY2025-H1Revenue decline as large-scale projects subside, with focus on smaller projectsAnnual report

    「As anticipated, demand growth driven by subsidies and other factors has tapered off, and equipment and supplies revenue fell 5.8% year on year. With few new construction, relocation or major equipment renewal projects this fiscal year, the company will continue to focus on identifying projects for low-priced equipment.」

    Demand growth driven by subsidies and other factors has tapered off, and equipment and supplies revenue fell 5.8% year on year. In an environment with few new construction, relocation or major equipment renewal projects, the company is focusing on identifying projects for low-priced equipment.
  4. FY2024AdvancedAnnual report

    「Although there were few new construction, relocation or opening projects, revenue from equipment and supplies increased 25.3% year on year, significantly improving performance, due to the acquisition of large-scale equipment and supplies such as MRI and CT systems and increased efforts to identify projects for small equipment such as ultrasound diagnostic systems, which have continued from the previous fiscal year.」

    Even in an environment with few new construction and relocation projects, equipment and supplies revenue continued to expand, driven by orders for large-scale equipment such as MRI and CT systems and intensified efforts to identify projects for ultrasound diagnostic equipment and other products. For the full year, equipment and supplies revenue increased 19.8% from the previous fiscal year.
  5. FY2024-Q3AdvancedAnnual report

    「Although there were few new construction, relocation or opening projects, revenue from equipment and supplies increased 25.3% year on year, significantly improving performance, due to the acquisition of large-scale equipment and supplies such as MRI and CT systems and increased efforts to identify projects for small equipment such as ultrasound diagnostic systems, which have continued from the previous fiscal year.」

    Even in an environment with few new construction and relocation projects, equipment and supplies revenue increased 25.3% year on year, driven by orders for large-scale equipment such as MRI and CT systems and intensified efforts to identify projects for ultrasound diagnostic equipment and other products. Unit sales of self-service payment terminals for clinics are also increasing as a result of the strengthened sales structure.
  6. FY2024-Q2AdvancedAnnual report

    「Equipment and supplies revenue increased 18.9% year on year, driven by intensified efforts to identify capital investment projects, an initiative that has continued from the previous fiscal year. Sales of self-service payment terminals for clinics, a new business initiative, are also increasing in unit volume as the strengthened sales structure proves effective.」

    Equipment and supplies revenue increased 18.9% year on year due to intensified efforts to identify capital investment projects. Unit sales of self-service payment terminals for clinics are increasing as a result of the strengthened sales structure.
  7. FY2024-Q1AdvancedAnnual report

    「Equipment and supplies revenue increased 4.7% year on year, driven by intensified efforts to identify capital investment projects, an initiative that has continued from the previous fiscal year. Sales of self-service payment terminals for clinics, a new business initiative, are also increasing in unit volume as the strengthened sales structure proves effective.」

    Equipment and supplies revenue increased 4.7% year on year due to intensified efforts to identify capital investment projects. Unit sales of self-service payment terminals for clinics are increasing as a result of the strengthened sales structure.
  8. FY2023Equipment and supplies revenue declines from the reversal of large-scale projects, while self-service payment terminals expandAnnual report

    「Equipment and supplies revenue fell 17.7% from the previous fiscal year due to the reversal of new construction and relocation projects at multiple medical institutions in the previous fiscal year. Meanwhile, sales activities for self-service payment terminals for clinics, a new business initiative, including inside sales and online meetings, are driving an increase in units sold.」

    Equipment and supplies revenue fell 17.7% from the previous fiscal year due to the reversal of multiple new construction and relocation projects, while sales of self-service payment terminals for clinics are being expanded through inside sales and online meetings.
  9. FY2023-Q3Continued revenue decline from the reversal of large-scale projects and pursuit of alternative projectsAnnual report

    「Revenue from equipment and supplies declined 20.7% year on year due to the backlash from new construction and relocation projects at multiple medical institutions in the previous fiscal year. No new construction or relocation projects are expected in the current fiscal year, but the company will focus on identifying capital investment projects for the next fiscal year and beyond.」

    Equipment and supplies revenue fell 20.7% year on year due to the reversal of multiple new construction and relocation projects in the previous fiscal year. The company does not anticipate new construction or relocation projects this fiscal year and says it will focus on identifying other capital investment projects for the following fiscal year and beyond.
  10. FY2023-Q2Continued revenue decline from the reversal of large-scale projects and pursuit of alternative projectsAnnual report

    「Revenue from equipment and supplies declined 23.3% year on year due to the backlash from new construction and relocation projects at multiple medical institutions in the previous fiscal year. No new construction or relocation projects are expected in the current fiscal year, but the company will focus on identifying other capital investment projects.」

    Equipment and supplies revenue fell 23.3% year on year due to the reversal of multiple new construction and relocation projects in the previous fiscal year. The company says it will focus this fiscal year on identifying capital investment projects other than new construction and relocation projects.
  11. FY2023-Q1Revenue decline from the reversal of large-scale projects and pursuit of alternative projectsAnnual report

    「Revenue from equipment and supplies declined 13.4% year on year due to the backlash from new construction and relocation projects at multiple medical institutions in the previous fiscal year. No new construction or relocation projects are expected in the current fiscal year, but the company will focus on identifying other capital investment projects.」

    Equipment and supplies revenue fell 13.4% year on year due to the reversal of the previous fiscal year's new construction and relocation projects. The company says it will focus this fiscal year on identifying capital investment projects other than those categories.
  12. FY2022AdvancedAnnual report

    「Revenue from equipment and supplies increased 21.2% from the previous fiscal year and significantly drove current-period performance, as the company secured more equipment and supplies than expected in medical institution rebuilding projects and sales of low-value equipment such as negative-pressure systems and air purifiers remained strong, supported by supplementary budgets for COVID-19 measures.」

    Equipment and supplies revenue increased 21.2% from the previous fiscal year, driven by rebuilding projects at medical institutions and sales of low-priced equipment related to COVID-19 countermeasures, contributing to overall performance.
  13. FY2022-Q3AdvancedAnnual report

    「Equipment and supplies revenue increased 20.3% year on year, reflecting new construction and relocation projects at medical institutions and continued strong sales of low-priced equipment, such as negative-pressure units and air purifiers, supported by supplementary budgets for COVID-19 countermeasures and other factors.」

    Equipment and supplies revenue increased 20.3% year on year, driven by new construction and relocation projects at medical institutions and sales of negative-pressure units, air purifiers and other products supported by supplementary budgets for COVID-19 countermeasures.
  14. FY2022-Q2AdvancedAnnual report

    「Equipment and supplies revenue increased 34.3% year on year, reflecting new construction and relocation projects at medical institutions and continued strong sales of low-priced equipment, such as negative-pressure units (Note 4) and air purifiers, supported by supplementary budgets for COVID-19 countermeasures and other factors.」

    Equipment and supplies revenue increased 34.3% year on year, driven by new construction and relocation projects at medical institutions and sales of negative-pressure units, air purifiers and other products supported by supplementary budgets for COVID-19 countermeasures.
  15. FY2022-Q1AdvancedAnnual report

    「Equipment and supplies revenue increased 52.5% year on year, reflecting new construction and relocation projects at medical institutions and strong sales of low-priced equipment, such as negative-pressure units (Note 6) and air purifiers, supported by supplementary budgets for COVID-19 countermeasures and other factors.」

    Equipment and supplies revenue increased 52.5% year on year, driven by new construction and relocation projects at medical institutions and sales of negative-pressure units, air purifiers and other products supported by COVID-19 countermeasure budgets.
  16. FY2021AdvancedAnnual report

    「There was budget spending related to COVID-19 measures, including ECMO systems (respiratory treatment systems using extracorporeal blood circulation), ventilators and equipment and supplies used for infection prevention. In addition, the company steadily secured equipment and supply replacement projects, driving a 33.2% increase from the previous fiscal year.」

    Equipment and supplies revenue increased 33.2% from the previous fiscal year, driven by orders for COVID-19 response-related ECMO systems, ventilators and infection-control equipment, as well as equipment renewal projects.
  17. FY2021-Q3AdvancedAnnual report

    「There was budget spending related to COVID-19 measures, including ECMO systems (respiratory treatment systems using extracorporeal blood circulation), ventilators and equipment and supplies used for infection prevention. In addition, the company secured equipment and supply replacement projects steadily, resulting in a 29.3% year-on-year increase.」

    Equipment and supplies revenue increased 29.3% year on year, driven by orders for COVID-19 response-related ECMO systems, ventilators and infection-control equipment, as well as equipment renewal projects.
  18. FY2021-Q2Equipment and supplies revenue growth driven by COVID-19 response demandAnnual report

    「Equipment and supplies revenue increased 6.1% year on year, supported by budget spending on COVID-19 response measures, including ECMO systems (extracorporeal membrane oxygenation systems for respiratory treatment) and ventilators.」

    Equipment and supplies revenue, which had continued to decline due to the reversal of rush demand and large-scale projects through the previous fiscal year, increased 6.1% year on year as COVID-19 response-related budgets were deployed for ECMO systems, ventilators and other products.
  19. FY2021-Q1Equipment and supplies revenue decline continues following the reversal of rush-demand-driven special demandAnnual report

    「Revenue from equipment and supplies declined 39.1% year on year due to the backlash from rush special demand ahead of the consumption tax increase in the previous fiscal year.」

    Equipment and supplies revenue continued to decline in the quarter due to the reversal of the rush-demand-driven special demand ahead of the consumption tax increase in the previous fiscal year.
  20. FY2020Full-year revenue decline continues due to the reversal of large-scale projectsAnnual report

    「Revenue from equipment and supplies was close to the initial forecast, but declined 12.6% from the previous fiscal year because the impact of the large-scale rebuilding and relocation projects at medical institutions in the previous year was substantial.」

    Although equipment and supplies orders were roughly in line with the initial forecast, full-year revenue fell 12.6% from the previous fiscal year due to the reversal of the previous year's large-scale rebuilding and relocation projects.
  21. FY2020-Q3Revenue declines amid the reversal of large-scale projects, while gross profit is maintainedAnnual report

    「Revenue from equipment and supplies declined 10.4% year on year, as the impact of the large-scale rebuilding and relocation projects in the previous year was substantial, despite orders exceeding initial expectations. Meanwhile, the company worked to secure profits and maintained gross profit at the previous year’s level.」

    Although orders exceeded the initial forecast, revenue fell 10.4% year on year due to the reversal of the previous year's large-scale rebuilding and relocation projects. Gross profit was maintained at the previous year's level through profit preservation measures.
  22. FY2020-Q2Sales decline continues as large projects reverseAnnual report

    「Revenue from equipment and supplies declined 20.1% year on year. Although the company secured orders exceeding its initial expectations from rush demand ahead of the October 2019 consumption tax increase, its results did not match those of the large-scale rebuilding and relocation projects in the previous year.」

    Although orders exceeded the initial forecast due to rush demand ahead of the consumption tax increase, equipment and supplies revenue fell 20.1% year on year, as it was below the level of the previous year's large-scale rebuilding and relocation projects.
  23. FY2020-Q1AdvancedAnnual report

    「Revenue from equipment and supplies increased 84.9% year on year because the company received orders for various types of equipment, substantially exceeding its initial expectations, in response to special demand ahead of the October 2019 consumption tax increase.」

    Orders for various types of equipment exceeded initial expectations due to unusually strong demand ahead of the consumption tax increase in October 2019, and equipment and supplies sales increased 84.9% from the year-earlier level.
  24. FY2019Full-year sales decline continues as unusually strong demand reversesAnnual report

    「Although there was special demand for new construction in addition to customer upgrades to modalities such as large-scale diagnostic imaging equipment typified by CT, MRI and ultrasound systems, the scale of special demand did not reach that of the previous fiscal year, and revenue declined 12.8% year on year.」

    Although there was unusually strong demand for modality updates and new construction, it was below the scale of large projects in the previous fiscal year, and the decline in equipment and supplies sales continued for the full year.
  25. FY2019-Q3Sales decline widens as large projects reverseAnnual report

    「Although there was special demand for new construction in addition to customer upgrades to modalities such as large-scale diagnostic imaging equipment typified by CT, MRI and ultrasound systems, the scale of new construction and rebuilding projects did not reach the previous fiscal year’s level, and revenue was 83.7% of the same period of the previous year.」

    Although there was unusually strong demand for modality updates and new construction, the scale of projects did not reach that of the previous fiscal year, and equipment and supplies sales fell to 83.7% of the year-earlier level. The decline widened from 92.4% in the previous quarter.
  26. FY2019-Q2Sales decline narrows despite the reversal of large projectsAnnual report

    「Although there was special demand for new construction in addition to customer upgrades to modalities such as large-scale diagnostic imaging equipment typified by CT, MRI and ultrasound systems, the scale of new construction and rebuilding projects did not reach the previous fiscal year’s level, and revenue was 92.4% of the same period of the previous year.」

    Although there was unusually strong demand for modality updates and new construction, sales continued to decline as the scale of projects did not reach that of the previous year's new construction and renovation projects. Meanwhile, the year-on-year ratio improved from 58.9% in the first quarter to 92.4%.
  27. FY2019-Q1Sales decline widens as large projects reverseAnnual report

    「Although there were large projects, including customer upgrades to modalities such as large-scale diagnostic imaging equipment typified by CT, MRI and ultrasound systems, the impact of multiple new construction and rebuilding projects in the previous year could not be fully offset, and revenue was 58.9% of the same period of the previous year.」

    Although there were large projects such as modality updates, equipment and supplies sales fell to 58.9% of the year-earlier level, as they could not offset the reversal of unusually strong demand from multiple new construction and renovation projects in the previous year.
  28. FY2018Full-year sales decline due to the reversal of unusually strong demandAnnual report

    「Sales of large projects, including equipment updates associated with customer facility rebuilding and various modality updates, as well as low-value equipment, progressed steadily. However, due to the effect of unusually strong demand in the previous year, sales fell to 91.6% of the previous fiscal year.」

    Although sales of large projects and low-value equipment progressed, equipment and supplies sales fell to 91.6% of the previous fiscal year due to the reversal of unusually strong demand in the previous year.
  29. FY2018-Q3Sales decline narrows despite the reversal of unusually strong demandAnnual report

    「Sales of equipment and supplies progressed steadily, including large-scale projects involving equipment upgrades associated with customer facility rebuilds and upgrades of various modalities, such as large diagnostic imaging equipment including CT, MRI and ultrasound systems, as well as sales of low-cost supplies. However, sales were 92.9% of the same period of the previous year due to the impact of the major special-demand surge in the previous year.」

    Sales of large projects and low-value equipment progressed, but sales continued to decline due to the reversal of unusually strong demand in the previous year. The year-on-year ratio improved from 88.3% in the second quarter to 92.9%.
  30. FY2018-Q2Sales decline widens as unusually strong demand in the previous year reversesAnnual report

    「Although there were large projects involving equipment updates associated with customer facility rebuilding and updates to various modalities, including CT, MRI and ultrasound systems, sales were affected by the reversal of unusually strong demand in the previous year and fell to 88.3% of the year-earlier level.」

    Although there were large projects to update equipment and modalities, the reversal of unusually strong demand in the previous year continued, and sales fell to 88.3% of the year-earlier level.
  31. FY2018-Q1Sales decline due to the reversal of large one-off demandAnnual report

    「Although there were large projects involving equipment updates associated with customer facility rebuilding and updates to various modalities, including CT, MRI and ultrasound systems, sales were affected by the reversal of unusually strong demand in the previous year and fell to 95.7% of the year-earlier level.」

    Although there were large projects to update customer facilities and modalities, equipment and supplies sales fell to 95.7% of the year-earlier level due to the reversal of unusually strong demand in the previous year.
  32. FY2017AdvancedAnnual report

    「We successfully converted demand for operating-room equipment and modalities, including CT, MRI and ultrasound systems, into orders. As a result, equipment and supplies sales reached 109.9% of the previous fiscal year.」

    Demand for operating-room equipment and modalities was converted into orders, bringing equipment and supplies sales to 109.9% of the previous fiscal year.
  33. FY2017-Q3AdvancedAnnual report

    「We successfully converted demand for modalities, including CT, MRI and ultrasound systems, and operating-room equipment into orders. As a result, equipment and supplies sales reached 113.8% of the year-earlier level.」

    Demand for modalities and operating-room equipment was converted into orders, bringing equipment and supplies sales to 113.8% of the year-earlier level.
  34. FY2017-Q2AdvancedAnnual report

    「Equipment and supplies sales reached 142.2% of the year-earlier level, as demand for operating-room equipment and modalities, including CT, MRI and ultrasound systems, was successfully converted into orders.」

    Demand for operating-room equipment and modalities was converted into orders, bringing equipment and supplies sales to 142.2% of the year-earlier level.
  35. FY2017-Q1AdvancedAnnual report

    「Equipment and supplies included sales related to customer facility rebuilding and the sale of systems for managing data received from imaging equipment. Sales reached 174.6% of the year-earlier level.」

    In addition to rebuilding demand from customers, we sold systems for managing data from imaging equipment, bringing equipment and supplies sales to 174.6% of the year-earlier level.
  36. FY2016First statedAnnual report

    「Orders for large-scale equipment and modalities, including CT, MRI and ultrasound systems, were received in connection with the rebuilding of a major customer facility, resulting in a 12.5% increase in equipment and supplies sales from the previous fiscal year.」

    We are converting rebuilding demand from major customers into orders for large-scale equipment and diagnostic imaging systems.
Moved together

"Expanding the medical equipment business with consumables as a growth driver" moved the same way as this thread, in the same document, in 14 of its 36 moves.

141411665★123456
  1. ★This thread
  2. 1Expanding the medical equipment business with consumables as a growth driver14×
  3. 2Expanding the customer base, centered on home-care rentals14×
  4. 3Coexistence of sales growth and profit decline11×
  5. 4Expanding the SPD business through new contracts with large facilities6×
  6. 5Deepening mature fields and developing new areas of healthcare6×
  7. 6Introducing performance-linked bonuses and delegating decisions to the nomination and compensation committee5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
OLBA DVx HEALTHCARE's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding orders for large-scale equipment and modalities | OLBA DVx HEALTHCARE,Inc. (2689) | Komori